[53] our analysis demonstrated that KDM6A‐mut signature scores correlate with downregulation of critical immune pathways, particularly TCR, BCR, and chemokine signaling, highlighting a conserved mechanism of immune suppression in BC. Here, KDM6A is linked to breast cancer.